Three wins needed to deliver new TB vaccines this decade
The TB Vax ARM outlines three key advocacy wins for the field to achieve by 2026 in order to effectively advance TB vaccine development. Check them out and sign a petition to show your support!
This World TB Day, the TB Vax ARM has outlined three key advocacy wins for the field to achieve by 2026 in order to effectively advance TB vaccine development and ensure their equitable and affordable access this decade. The TB Vax ARM will use these wins as advocacy guideposts for the coming two years, including an assessment of progress ahead of World TB Day 2025.
Advocates around the world are invited to endorse the TB Vax ARM wins as a call to action to world leaders, vaccine developers, and funders.
Check them out here and sign a petition to show your support!
***************
The three wins will be explored during a webinar on 4 April 2024. You can register here.
***************
The TB Vaccine Advocacy Roadmap (TB Vax ARM) represents a global coalition of TB stakeholders, including TB survivors, civil society organizations, and non-profits, invested in TB vaccine advocacy and research. The coalition is led by IAVI, the Treatment Action Group, the Stop TB Partnership Working Group on New TB Vaccines, Results UK, the Global TB Caucus, and members of TB affected communities.
Source: TB Vax ARM
